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Abstract
OBJECTIVES—Evidence suggests an association between maternal vitamin C levels and preterm
premature rupture of membranes (PROM) or preterm labor. The objective of this study was to
estimate whether maternally administered vitamins C and E lowers the risk of spontaneous preterm
birth (SPB).
METHIODS—This is a secondary analysis of a randomized, double-masked, placebo-controlled
trial in low-risk nulliparous women administered 1000 mg vitamin C and 400 IU vitamin E or placebo
daily from 9-16 weeks’ gestation until delivery. Outcomes include preterm birth due to PROM and
total spontaneous preterm births (SPB due to PROM or spontaneous labor).
RESULTS—Of the 10,154 women randomized, outcome data were available on 9,968 (4,992
vitamin group and 4,976 placebo group). 1,038 women (10.4%) delivered preterm of whom 698
(7.0%) had a SPB. A SPB occurred in 356 women (7.1%) assigned to daily vitamin C/E
suplementation and in 342 (6.9%) assigned to placebo. There were 253 women (2.5%) delivered
after preterm PROM and 445 (4.5%) after a spontaneous preterm labor. In women supplemented
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with vitamins C and E, births attributed to preterm PROM were similar at less than 37 and 35 weeks
gestation but were less frequent before 32 weeks gestation (0.3% vs. 0.6% adjusted OR 0.3-0.9).
However, total spontaneous preterm births across gestation in women supplemented with vitamins
C and E or a placebo were similar.
CONCLUSION—Maternal supplementation with vitamins C/E beginning at 9 to 16 weeks gestation
in low risk nulliparous women did not reduce spontaneous preterm births. (Clinical Trials.gov
number NCT00135707)
Birth prior to 37 weeks gestation (preterm) has increased since 1990 and was 12.7% of all
births in the U.S. in 2007.(1) There has been consistency among reports that about one-fourth
of preterm births are indicated due to various factors, primarily maternal hypertensive
conditions, and three-fourths occur spontaneously with or without preterm premature ruptured
membranes (PROM).(2-3) In all women with a spontaneous preterm birth, the contribution of
premature membrane rupture has been estimated to be up to one-third with two-thirds due to
spontaneous labor.(4) Preterm premature membrane rupture has been associated with many
factors, including ascorbic acid deficiency (vitamin C).(4-7) These observations are of great
importance because if vitamin C supplementation reduces the occurrence of preterm PROM a
deficiency of vitamin C is a modifiable risk factor and supplementation would be a corrective
interventional behavior.
Our intent was to further assess the hypothesis that daily maternal antioxidant supplementation
with vitamins C and E from early pregnancy would reduce the incidence of spontaneous
preterm birth due to either spontaneous labor or preterm PROM. To test this hypothesis we
accomplished a secondary analysis of the NICHD Maternal-Fetal Medicine Units Network
multicenter randomized, double-masked trial of low risk nulliparas assigned to daily vitamin
C and E supplementation or matching placebo to reduce adverse outcomes due to pregnancy
associated hypertension.(8)
MATERIALS AND METHODS
The trial was conducted at the sixteen clinical centers that were members of the Eunice Kennedy
Shriver National Institutes of Child Health and Human Development Maternal-Fetal Medicine
Units (MFMU) Network between 2003 and 2008. Full details of the study design and technique
of data collection have been previously described.(8) Women with a singleton pregnancy
between 9 weeks 0 days and 16 weeks 6 days of gestation were eligible if they had not
experienced a prior pregnancy lasting beyond 19 weeks 6 days. Gestational age was determined
before randomization by a previously described algorithm(9) using the date of the last
menstrual period (if reliable) and results of the earliest ultrasound examination. Women were
not eligible if they had elevated systolic (135 mm Hg or higher) or diastolic (85 mm Hg or
higher) blood pressure or proteinuria (at least 300 mg by 24-hour urine collection or 1+ protein
by dipstick), were prescribed antihypertensive medication, or were taking more than 150 mg
vitamin C or more than 75 IU vitamin E daily. Other exclusion criteria were pregestational
diabetes, treatment with antiplatelet drugs or nonsteroidal anti-inflammatory agents, uterine
bleeding within the week prior to recruitment, uterine malformation, serious medical
complication, known fetal anomaly or aneuploidy, in vitro fertilization resulting in the current
pregnancy, or illicit drug or alcohol abuse. Eligible and consenting women were randomly
assigned to capsules containing a combination of 1000 mg vitamin C (ascorbic acid) and 400
IU of vitamin E (RRR alpha tocopherol acetate) or matching placebo (mineral oil). Both the
vitamin and placebo capsules were manufactured by Strides, which had no role in the design
of the study, the analysis or interpretation of the data, the preparation of the manuscript, or the
decision to submit the manuscript for publication. The simple urn method, with stratification
according to clinical center, was used by the data coordinating center to create a randomization
sequence.(10)
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The study was double-masked. Certified research staff collected information on the women's
demographic features, medical history, social history at enrollment, and neonatal and maternal
outcomes at delivery. The study was approved by the institutional review boards of each clinical
site and the data coordinating center. All participants provided written informed consent before
enrollment.
The occurrence of spontaneous preterm births (due to preterm PROM or to spontaneous
preterm labor) in women randomized to vitamin or placebo supplementation was a planned
secondary outcome of the original trial. Preterm birth was defined as prior to 37 weeks’
gestation and as an indicated or a spontaneous preterm birth. Spontaneous preterm birth
included spontaneous labor with or without subsequent intrapartum oxytocin augmentation.
Similar to some prior MFMU Network trials, preterm premature rupture of membranes was
defined as spontaneous rupture of membranes and one of the following criteria: membrane
rupture 60 minutes or more before onset of labor, labor induced for pre-labor ruptured
membranes, or no labor and onset of rupture 60 minutes or more before delivery.
Data from all women were analyzed according to the group to which they were randomized,
regardless of whether they took the study capsules. Continuous variables were compared using
the Wilcoxon rank-sum test, and categorical variables with the chi-square test. Logistic
regression was used to calculate odds ratios and the multivariable analysis included race or
ethnic group, smoking, body mass index at baseline (9-16 weeks gestational age) and clinical
center. Survival analysis, using the Kaplan-Meier method, was performed to estimate whether
treatment with vitamins was associated with a longer time to rupture (censoring at term). For
each of the outcomes, the Breslow-Day test for homogeneity was used to estimate if there was
a difference in the effect among women who started treatment prior to 13 weeks’ gestation
compared with those that started on or after 13 weeks’ gestation. For all statistical tests, a
nominal p value less than 0.05 was considered to indicate statistical significance; no
adjustments were made for multiple comparisons. Analyses were performed using SAS
software (Cary, NC).
RESULTS
Figure 1 details the enrollment, randomization and follow-up of the participants in this trial.
A total of 10,154 women were randomized and outcome data was available on 9,969 women.
One woman who died and never delivered her baby was excluded, leaving 9,968 women for
this analysis (4,992 vitamins and 4,976 placebo). Baseline characteristics were similar between
the two groups (Table 1). Seventy-seven percent of enrolled subjects were taking a prenatal or
multivitamin when they were randomized. The median ratio of the number of study capsules
taken to the number that should have been taken between randomization and delivery was 88%
in both treatment arms.
One thousand thirty-eight women delivered preterm of which 698 (7.0%) had a spontaneous
preterm birth (SPB). There were 253 women (2.5%) delivered after preterm PROM and 445
(4.5%) after a spontaneous preterm labor. A SPB less than 37 weeks’ gestation occurred in 356
women (7.1%) assigned to daily vitamin C/E supplementation and in 342 (6.9%) assigned a
placebo (p=0.61). These results were similar regarding SPB before 35 or 32 weeks gestation
(Table 2). Additionally, the survival analysis showed there was no difference in gestational
age at membrane rupture (censoring at term) between the two treatment groups (p=0.62, log
rank test). The frequency of SPB attributable to preterm PROM before 37 and before 35 weeks’
gestation in the vitamin supplemented and placebo groups were similar (Table 2.) However,
SPB before 32 weeks’ gestation and attributable to preterm PROM was less frequent in the
vitamin supplemented group (0.3% vs. 0.6%, adjusted OR 0.3-0.9). Because PROM remote
from term is often treated conservatively to prolong pregnancy, we also evaluated the impact
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of vitamin supplementation based on the gestational age at the time of membrane rupture.
Preterm PROM occurring before 32 weeks 0 days gestation was also less frequent in the women
supplemented with vitamins (0.36% vs. 0.64%, p=0.046). For each of the outcomes, the test
for homogeneity was not significant indicating there was no difference in the effect among
women who started treatment prior to 13 weeks’ gestation compared with women who started
at or after 13 weeks’ gestation.
Neonatal outcomes according to treatment group for the entire cohort have previously been
published.(8) Selected neonatal outcomes in the 698 women who had a spontaneous preterm
birth prior to 37 weeks gestation were similar between those assigned to daily vitamin and
placebo supplementation (Table 3).
DISCUSSION
We found a similar occurrence of spontaneous births prior to 37, 35, and 32 weeks’ gestation
in women assigned to daily vitamin C/E or to placebo treatment in a planned secondary analysis
of an NICHD Maternal-Fetal Medicine Units Network trial. The frequencies of preterm birth
before 37 and 35 weeks due to either preterm PROM or preterm labor were also similar between
groups. Our analysis does demonstrate less frequent preterm births before 32 weeks’ gestation
due to preterm PROM in women assigned to daily vitamin supplementation (0.30 % vs. 0.60
%], adjusted OR [95% CI] 0.50 [0.27, 0.93]), and also less frequent preterm PROM occurring
before 32 weeks gestation (0.36% vs. 0.64%, adjusted OR 0.56 [0.32, 1.00]). It is possible that
this single significant occurrence is due to the clinical imprecision of determining the SPB
subcategories of preterm PROM or spontaneous preterm labor. Spontaneous preterm labor and
or preterm PROM are precisely defined but are less precisely determined due to the difficulties
inherent in the “best estimate” of the onset of labor and or the timing of membrane rupture in
relation to the onset of contractions. Though we limited the diagnosis of PROM to those women
with onset of membrane rupture at least one hour before the onset of symptomatic contractions,
the possibility of incorrect categorization remains and should be considered. Further, the
presence of this statistically significant finding for a relatively uncommon finding and in the
absence of similar trend or pattern for other similar outcomes raises the possibility that the
result occurred because of a Type I (alpha) error. Most precisely, SPB includes all of the women
who had a preterm birth that was not indicated. We found no difference in SPBs across gestation
whether the women were assigned to daily vitamin supplementation or to a placebo. We also
found no benefit of daily maternal vitamin C/E supplementation for any of the pre-specified
outcomes of the neonates delivered preterm due to spontaneous birth.
Vitamin C deficiency has been associated with the occurrence of spontaneous preterm birth.
(4,5,6,10) Vitamin C is involved in collagen synthesis and may be important to maintain the
integrity of the chorioamnion membranes. Woods and colleagues(5) reported that reduced
midgestational levels of vitamin C are associated with preterm premature rupture of
membranes. They noted that reactive oxygen species generated in response to insults such as
infection, cigarette smoking, bleeding, or cocaine use can activate collagenolytic enzymes and
impair fetal membrane integrity. They hypothesized that an increase in dietary consumption
or supplementation of vitamin C and E during pregnancy might reduce the risk of that portion
of preterm premature rupture of membranes that may be mediated by oxidative injury to fetal
membranes. Plessinger and colleagues(11) reported that pre-treatment of human amnion-
chorion with vitamins C and E prevents hypochlorous acid-induced membrane damage.
Casanueva and colleagues(7) tested the hypothesis that maternal supplementation with a
relatively low dose of vitamin C (100 mg daily) would prevent SPB due to preterm PROM. In
their trial, mean leukocyte vitamin C concentrations decreased in the placebo group and
increased in the vitamin C group (p=0.001) and preterm PROM occurred in 14 of 57 (24.6%)
women assigned to placebo treatment and in 4 of 52 (7.6%) assigned to vitamin C (RR 0.26;
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95% CI [0.08, 0.83]). In a planned secondary analysis of a larger population, Spinnato and
associates (12) reported that women assigned to 1000 mg of daily maternal vitamin C and 400
IU of vitamin E or to a placebo had a similar occurrence of spontaneous preterm births. These
authors did report an increased frequency of preterm PROM among women randomized to
vitamin supplementation (16/349 [4.6%] vs. 6/348 [1.7%], p=0.025). In both of these reports,
and our analysis, the frequencies of total spontaneous births were not different between groups.
The conflicting findings regarding preterm PROM in the Casanueva trial, the Spinnato analysis,
and our analysis, further raise question regarding the veracity of our finding that vitamin C and
E supplementation reduces the frequency of preterm PROM before 32 weeks’ gestation. This
is particularly the case for combined vitamin C and E supplementation, as our analysis and the
Spinnato analysis had opposite results.
In summary, maternal supplementation with vitamin C and E did not reduce the occurrence of
spontaneous preterm birth. Neonatal outcomes of infants delivering preterm were similar in
preterm newborns whose mothers were randomized to treatment with vitamin C or E or a
placebo. Our results, taken in context with similar trials regarding vitamin C and E
supplementation, do not support either the clinical use for prevention of spontaneous preterm
birth or its neonatal sequelae or further trials of this treatment in similar low-risk populations.
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Table 1
Baseline Maternal Characteristics*
Vitamins N=4,992 Placebo N=4,976
Maternal age (years) 23.5 ± 5.2 23.5 ± 5.3
Weeks of gestation at randomization 13.4 ± 2.1 13.4 ± 2.1
Randomization ≤ 12 weeks 2,181 (43.7) 2,162 (43.4)
Race or ethnic group+
    African American 1,245 (24.9) 1,273 (25.6)
    Hispanic 1,559 (31.2) 1,524 (30.6)
    Other 2,188 (43.8) 2,179 (43.8)
Body-mass index at randomization (kg/m2) 26.3 ± 6.1 26.3 ± 6.1
Smoker 788 (15.8) 763 (15.3)
Educational level (years) 12.8 ± 2.7 12.8 ± 2.7
Prenatal or multivitamin usage 3,852 (77.2) 3,838 (77.1)
Daily dose of vitamin C (mg)
    Median 120 100
    Range 0-150 0-300
Daily dose of vitamin E (IU)
    Median 22 22
    Range 0-100 0-100
Previous pregnancy 1,138 (22.8) 1,149 (23.1)
P ≥ 0.05 for all between-group comparisons.
*
Plus-minus values are means ± standard deviation
+
Race or ethnic group was self-reported.
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Table 2
Spontaneous preterm birth and preterm PROM prior to 37, 35 and 32 weeks’ gestation.*
Outcome Vitamins N=4,992 Placebo N=4,976 OR [95% CI] Adjusted OR# [95% CI]
SPB < 37 weeks 356 (7.1) 342 (6.9) 1.04 [0.89, 1.21] 1.05 [0.90, 1.22]
SPB < 35 weeks 177 (3.6) 185 (3.7) 0.95 [0.77, 1.17] 0.96 [0.77, 1.18]
SPB < 32 weeks 109 (2.2) 124 (2.5) 0.87 [0.67, 1.13] 0.88 [0.67, 1.14]
SPB due to preterm PROM <37 weeks 124 (2.5) 129 (2.6) 0.96 [0.75, 1.23] 0.96 [0.75, 1.23]
SPB due to preterm PROM <35 weeks 56 (1.1) 58 (1.2) 0.96 [0.66, 1.39] 0.97 [0.67, 1.40]
SPB due to preterm PROM <32 weeks 15 (0.3) 30 (0.6) 0.50 [0.27, 0.92] 0.50 [0.27, 0.93]
Preterm PROM <37 weeks 130 (2.6) 132 (2.7) 0.98 [0.77, 1.25] 0.98 [0.77, 1.26]
Preterm PROM <35 weeks 58 (1.2) 61 (1.2) 0.95 [0.66, 1.36] 0.95 [0.66, 1.37]
Preterm PROM <32 weeks 18 (0.4) 32 (0.6) 0.56 [0.31, 1.00] 0.56 [0.32, 1.00]
*
Presented as number (%). SPB total spontaneous preterm births (preterm PROM or preterm labor), preterm PROM preterm premature rupture of
membranes.
#
Adjusted for race, smoking, baseline body mass index and center.
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Table 3
Neonatal outcomes for spontaneous preterm births occurring before 37 weeks.*
Vitamins N=356 Placebo N=342 p-value
Fetal/neonatal death 72 (20.5) 80 (23.5) 0.33
Fetal loss < 20 weeks 45 (12.6) 47 (13.7) 0.67
Fetal death ≥ 20 weeks 8 (2.2) 10 (2.9) 0.57
Neonatal death 19 (5.4) 23 (6.8) 0.45
SGA < 3rd centile† 3 (1.0) 8 (2.8) 0.10
LBW < 2500 (grams)† 157 (52.0) 160 (56.5) 0.27
Apgar score ≤ 3 at 5 minutes† 14 (4.7) 17 (6.0) 0.48
RDS† 56 (18.6) 49 (17.3) 0.67
Sepsis† 20 (6.6) 11 (3.9) 0.13
Necrotizing enterocolitis† 8 (2.7) 8 (2.8) 0.91
IVH (grade III and IV)† 5 (1.7) 7 (2.5) 0.49
Retinopathy of prematurity† 16 (5.3) 13 (4.6) 0.68
NICU admission† 149 (49.2) 142 (50.0) 0.84
*
Presented as number (%). SGA small for gestational age, LBW low birth weight, NICU neonatal intensive care unit, RDS respiratory distress
syndrome, IVH intraventricular hemorrhage.
†
Live births only (303 in the Vitamins group and 285 in the Placebo group).
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